(S)-8,14-Dihydroxy Efavirenz

Product Description
CAT No.
ALN-E003026
CAS No.
252343-27-4
Mol. F.
C14H9ClF3NO4
Mol. Wt.
347.7
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : (S)-6-Chloro-8-hydroxy-4-((1-hydroxycyclopropyl)ethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one
Smiles : OC1(CC1)C#C[C@@](C2=CC(Cl)=CC(O)=C2NC3=O)(O3)C(F)(F)F
Technical Data
Reference
Development and validation of a HPLC analytical assay method for efavirenz tablets: a medicine for HIV infections
Osnir de Su00e1 Viana1 , Flu00e1via Patru00edcia Morais Medeiros2 , Severino Grangeiro-Ju00fanior2 , Miracy Muniz Albuquerque1 , Mu00f4nica Felts La Roca Soares1-3, Josu00e9 Lamartine Soares-Sobrinho1-3, Lariza Darlene Santos Alves1 , Larissa Arau00fajo Rolim1 , Keyla Emanuelle Ramos da Silva1 , Pedro Josu00e9 Rolim-NetonBraz. J. Pharm. Sci. vol.47 no.1 Su00e3o Paulo Jan./Mar. 2011
Investigation of the solvent-dependent photolysis of a nonnucleoside reverse-transcriptase inhibitor, antiviral agent efavirenz
Maryam A Jordaan and Michael Shapi – Antiviral Chemistry and Chemotherapy 2017: 1–11
Method Development and Validation for Related Impurities of Efavirenz by RP-HPLC Method
Desaraju Bhargavi, Bhukya Babu Rao, Gangarapu Kiran, Thumma Gouthami & Vasudha Bakshi – TACL 7 (5) 2017 pp 737 – 747
RFQ